Effect of verapamil on Enterococcus faecalis, Escherichia coli and on DNA damage induced by copper and iron by Gumus, Gulsum  Kubra & Arman, Ibrahim 
Indian Journal of Experimental Biology 
Vol. 59, November 2021, pp. 791-797 
Effect of verapamil on Enterococcus faecalis, Escherichia coli and on 
DNA damage induced by copper and iron 
Gulsum Kubra Gumus & Ibrahim Arman* 
Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Bulent Ecevit University, Zonguldak, Turkey 
Received 09 October 2020; revised 02 October 2021 
Verapamil is commonly used oral drug for treatment of high blood pressure and heart diseases worldwide. Here, we 
investigated the effect of verapamil on two of human intestinal flora bacterial strains Enterococcus faecalis and Escherichia 
coli using the broth medium dilution method and agar disc diffusion method. In addition, DNA was treated with verapamil, 
verapamil plus H2O2, verapamil plus ascorbic acid, verapamil plus iron and verapamil plus copper and analyzed by agarose 
gel electrophoresis. The interaction of verapamil with DNA was investigated by UV-Vis spectrophotometer and in silico 
methods. Verapamil inhibited the growth of both E. faecalis and E. coli up to 90% at concentrations of 9, 18 and 25 mM. 
The concentration of 9 mM (480 mg dose) of the drug was found as both MIC and MBC value for the two bacterial strains. 
The drug did not show any breaking or protective effect on the supercoiled plasmid DNA. In the UV-Vis spectrophotometer 
analysis, verapamil did not show any interaction with the DNA. In contrast, in silico analysis showed the drug to bind to a 
minor groove of double helix DNA by hydrogen bonds and hydrophobic interactions with the binding energy of 
7.3 kcal/mol and binding constant (Kb) value of 2.3×10
5 M-1.
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Verapamil is a calcium channel blocker used to treat 
hypertension, and it has been reported as an inhibitor of 
P-gp and some CYP enzymes
1
. It is used for the 
treatment, control and prevention of high blood 
pressure, heart diseases and migraine diseases. Since 
antihypertensive drugs show heterogeneity as a 
chemical, they have recently attracted the attention of 
many researchers to study the drugs in terms of side 
effects
2
. Al-harthy and coworkers
3
 reported 
that addition of verapamil enhances the cytotoxic 
 effect of doxorubicin against the growth of 
MCF-7 cells. Jaferiyan and his co-workers
4
 
showed that verapamil enhances the cytotoxic 
effects of docetaxel and vinblastine combined 
therapy against non-small cell lung cancer cell 
lines. Milosevic et al.
5
 who investigated the effect 
of verapamil hydrochloride on human lymphocytes 
using the Micronucleus test and the Fish method, 
showed that 100 µM of verapamil had a significant 
cytotoxic effect. Verapamil is commercially available as 
capsules, tablets and injectable forms (https://www.drug 
bank.ca/drugs/DB00661). 
DNA (Deoxyribonucleic acid) is an important 
material in maintaining cell life. The study of Drug-
DNA interactions is an interesting and important issue 
both in understanding the interaction mechanism and 
in the design of new drugs. The minor groove of DNA 
is sensitive to the attacks of small drug molecules. 
Depending on the chemical structure of drugs, they 
show selectivity for some nucleophilic parts of DNA
6
. 
Cells have many endogenous antioxidant systems to 
ensure a balance between ROS and antioxidants
7
. 
Increased levels of the reactive oxygen, decreased 
levels of antioxidant enzymes and insufficient DNA 
repair mechanisms lead to oxidative DNA damages 
including single and double strands breaks and base 
modifications
8
. Therefore, the primary cause of cell 
death can result from oxidative DNA damages. The 
exogenous sources of free radicals are drugs, metal 
ions, pollutants and radiation. Metal ions react with 
H2O2 in biological systems to produce highly reactive 
radicals such as hydroxyl radicals resulting in 
oxidative DNA damage
9
. In a study, it was observed 
that the interaction of pyrimidine, β-amino alanine 
and β-hydroxy imidazole with Fe (II) in the 
Bleomycin caused DNA damage
6
.  
There is an ecological balance between the human 
host and microorganisms that colonize mucous 
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surfaces. The normal microflora represents a complex 
and important ecological system and alterations in the 
flora may give rise to serious clinical implications. 
Administration of antimicrobial agents causes 
disturbances in the ecological balance between host 
and microorganisms
10
. Since verapamil is 
administered orally to cardiac patients, it is in direct 
contact with microbiota in the gastrointestinal tract for 
a long time
11
. Verapamil has been shown to have an 
antimicrobial potentiating effect in the treatment of 
Mycobacterium tuberculosis
12
. Also, verapamil at 
high concentrations (400-800 µg/mL level) has been 
reported to produce inhibitory action against some 
bacterial strains, such as Bacillus leicheniformis 
10341, Staphylococcus aureus NCTC 6571 and 
Escherichia coli K12Row
13
. In this study, we 
investigated the effect of verapamil on DNA strand 
breakage induced by copper and iron and also the 
effect of the drug on the growth of Escherichia coli 
and Enterococcus faecalis commonly found in the 
human intestine.  
Materials and Methods 
In this study, verapamil hydrochloride (catalog No. 
2811, Acros Organics) and E. coli ATCC-25922 and 
E. faecalis ATCC-29212 were used.
Preparation of plasmid DNA 
pUC19 plasmid DNA that had been previously 
transferred to the Escherichia coli NEB5α strain was 
purified. Plasmid purification was carried out 
following the EZ-10 Spin-Column Plasmid DNA 
Miniprep Kit (bio basic) protocol. Beer-Lambert's law 
and agarose gel (1%) electrophoresis were used to 
analyze the amount and purity of the DNA. 
Effect of verapamil hydrochloride on DNA 
To determine the DNA damaging potential of 
verapamil hydrochloride, 18.5 µM base pairs (bp) of 
pUC19 plasmid DNA was treated with 1850, 185, 
18.5, 1.85 and 0.185 µM of verapamil hydrochloride 
at 37°C for 45 min. The test was repeated in the 
presence of H2O2 (6 mM) as an oxidative agent and 
ascorbic acid (Asc) (60 µM) as a reducing agent. 
After incubation, the reaction mixtures were run in 
agarose gel (1%) electrophoresis at 55 volts for 55 
min, followed by staining with ethidium bromide. All 
of the tests were performed in phosphate saline buffer 
(PBS) (pH = 7.5)
14
. 
Effect of verapamil on iron-mediated DNA breakage 
In this part, 18.5 µM bp of pUC19 plasmid DNA 
were treated with 30 µM and 1.5 mM of FeSO4 plus 
different concentrations of verapamil hydrochloride 
(1850, 185 and 18.5 µM) using the procedure used by 
Li et al. 
15
. It was then incubated at 37°C for 1 h. A 
tube containing all of the ingredients except verapamil 
hydrochloride and another containing just untreated 
plasmid DNA were used as control samples. To 
examine the protective effects of verapamil 
hydrochloride on DNA against the oxidative agent, 
the pUC19 plasmid DNA was treated with 30 µM 
FeSO4 plus 30 µM H2O2 plus different concentrations 
of verapamil hydrochloride (1850, 185, 18.5, 1.85 and 
0.185 µM) and followed by incubation at 37°C for 1 h. 
After that, the reaction mixture was subjected to 
analysis on agarose gel (1%) electrophoresis for 55 min 
at 90 volts. All tests were performed in PBS (pH, 7.4) 
buffer. 
Effect of verapamil on copper mediated DNA breakage 
In order to study the effect of verapamil 
hydrochloride on DNA-copper interaction, 18.5 µM bp 
of pUC19 plasmid DNA were treated with 60 µM of 
CuCl2 plus different concentrations (1850, 185, 18.5, 
1.85 and 0.185 µM) of the drug at 37°C for 45 min. 
The reaction mixture was then subjected to analysis on 
a 1% agarose gel electrophoresis for 55 min at 90 volts. 
The tests were repeated by all of the ingredients plus 
Asc (60 µM). A plasmid DNA treated with no 
substance was used as a control sample. All tests were 
performed in PBS (pH, 7.4) buffer
16
. 
Binding activity of verapamil on DNA 
The interaction between verapamil hydrochloride 
and DNA was investigated by UV-Vis 
spectrophotometer and docking methods. At first, 
87 µM of calf thymus DNA that was dissolved in 
Tris-EDTA buffer (0.5 molar EDTA, and 50 mM 
Tris, pH 7.2) was titrated with 2 µL of verapamil 
hydrochloride (1.6 mM) and analyzed by absorption 
spectra recording in the range of 225-300 nm. After 
each verapamil hydrochloride addition, drug-DNA 
solutions were allowed to incubate for 5 min. The 
intrinsic DNA binding constant (Kb) was obtained 













where A0 is the absorption of DNA at 260 nm in the 
absence of verapamil hydrochloride; A∞ is the 
ultimate absorption in the presence of verapamil 
hydrochloride. A is the absorbance of verapamil 
hydrochloride-DNA. While the calf thymus DNA 
concentration was kept constant at 3.3 mM at pH 7.4, 
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the verapamil hydrochloride concentration varied 
between 0.16 mM and 1.6 mM. To study the 
verapamil -DNA interaction with docking method, the 
DNA sequence (PDB ID: 1BNA) was obtained from 
the Protein Database (https://www.rcsb.org/) in a 3D 
form and 3D form of verapamil was retrieved from 
PubChem (https://pubchem.ncbi.nlm.nih.gov/) database. 
Auto Dock Tools was used to prepare the DNA and 
verapamil hydrochloride files. The complex system 
was enclosed in a box with a number of grid points in 
x×y×z directions, (50×50×100), and a grid spacing of 
0.375 Å. The output from AutoDock was rendered 
with Discovery Studio tool
19
. 
Antibacterial effect of verapamil hydrochloride 
In this part, two flora bacterial strains (E. faecalis 
as a Gram positive strain and E. coli as a Gram 
negative strain) were inoculated into Mueller Hinton 
broth medium containing different concentrations of 
verapamil hydrochloride (0.75, 1.5, 9, 18 and 25 mM) 
followed by adjusting to standard turbidity of 
0.5 McFarland. After that, the cultures were incubated 
overnight at 37°C at 150 rpm. The growth of the 
strains was evaluated by UV-visible spectro-
photometry (Optizen 2120 UV) and CFU (colony 
forming units) counting. The lowest drug 
concentration that inhibited the growth of the strains 
was determined as MIC (minimum inhibition 
concentration) and the lowest drug concentration that 
killed the strains was determined as MBC (minimum 
bactericidal concentration). In addition, the bacterial 
strains of E. coli, E. faecalis were cultured on Mueller 
Hinton agar plats by spread plate technique. After that 
sterile blank discs containing 25, 18, 9, 1.5 and 
0.75 mM of verapamil hydrochloride were placed 
on the culture before incubation. Then the cultures 
were incubated at 37°C for an overnight and the 
antibacterial effect of the verapamil tried to assay by 
the zone diameter formed around the colonies
20
. 
Results and Discussion 
Effect of verapamil on DNA 
In the supercoiled plasmid DNA that was treated 
with different concentrations of verapamil 
hydrochloride, verapamil hydrochloride plus Asc and 
verapamil hydrochloride plus hydrogen peroxide 
were not shown any breakages in agarose gel 
electrophoresis (Fig. 1A). 
Effect of verapamil on iron mediated DNA damage 
Different concentrations of verapamil hydro-
chloride did not show any breaking activity on 
supercoiled plasmid DNA in the presence of iron. In 
addition, they could not show any protective effect 
against radical hydroxide originated by Fenton 
reaction (Fig. 1B).   
Effect of verapamil on copper mediated DNA damage 
Different concentrations of verapamil 
hydrochloride did not show any breaking activity on 
supercoiled plasmid DNA in the presence of copper. 
In addition, they could not protect supercoiled 
plasmid DNA against the damaging activity of copper 
plus Asc (Fig. 1C).   
DNA binding activity of verapamil 
At 260 nm, the initial absorbance value (0.575) of 
the DNA solution did not change significantly after 
titration with verapamil hydrochloride. As shown in 
Fig. 2, the verapamil hydrochloride-free DNA 
solution showed an absorbance peak at 260 nm, while 
Fig. 1 — Effect of verapamil hydrochloride on DNA in the 
presence of (A) reductive and oxidative agenet (Ascorbic acid 
(Asc) concentration was 60 µM and H2O2 concentration was 6 
mM); (B) iron (concentrations of FeSO4 were shown as a and b 
that presented 1.5 mM and 30 µM, respectively. The 
concentration of H2O2 was 30 µM); and (C) copper (CuCl2 and 
Asc were 60 µM). [pUC19 plasmid DNA was used as 18.5 µM 
bp. Different concentrations of verapamil hydrochloride are 
shown as a, b, c, d and e that representing 1850, 185, 18.5, 1.85 
and 0.185 µM, respectively] 
Fig. 2 — Ultra violet-Vis DNA-verapamil hydrochloride. The spectra 
have been recorded at wavelengths ranging 225-300 nm. 




the solution showed two absorbance peaks (at 235 and 
275 nm) after the addition of 165 µM verapamil 
hydrochloride. Verapamil hydrochloride itself has a 
maximum of UV absorption at 232 and 278 nm.  
Docking study showed that in the conformation 
with lowest ΔG, verapamil hydrochloride was located 
in the minor groove of double-helix DNA by making 
one hydrogen bond including DG4: O3 - Vera: O1, 
with the bond length of 3.15 Å, and hydrophobic 
bonds with some nucleotides (C3, G4, A5, A6 and T7 
from A chain and C8, C10 and T11 from B chain) 
(Fig. 3). The ligand conformer with the lowest 
binding energy and the one with the highest binding 
energy showed 7.32 and -2.09 kcal/mol, respectively 
(Table 1).  
 
Antibacterial effect of verapamil hydrochloride 
As it was shown in Figs 4 & 5 the concentration  
of 9 mM of verapamil hydrochloride was determined 
as MIC (minimum inhibition concentration) and  
MBC (minimum bactericidal concentration). The 
concentrations of 1.5 and 0.75 mM of verapamil 
hydrochloride caused to increase the growth of E. coli 
and E. faecalis as 6 and 9%, respectively. 
 
Discussion 
Damage to cellular DNA is involved in 
mutagenesis and the development of cancer. In order 
to explore DNA damage caused by chemicals, one of 
 
 
Fig. 3 — Molecular modeling of the hydrogen bonding interaction 
between verapamil and double helix DNA. The bonds shown by 
dashed lines represent hydrogenic bonds and the bonds shown by 
radius lines represent hydrophobic bonds. 
 
Table 1 — Docking summary of verapamil hydrochloride with DNA 






1 79 7.32 0 2.34×10
5 
2 57 7.22 0 1.97×10
5 
3 96 6.69 0 8.06×10
4 
4 10 6.1 0 2.98×10
4 
5 45 6.07 0 2.83×10
4 
6 52 5.96 0 2.35×10
4 
7 18 5.92 0 2.20×10
4 





Fig. 4 — Relative growth of E. faecalis and E. coli in medium 
containing various concentrations of verapamil hydrochloride. 
The CFU numbers of the control samples for E. faecalis and  
E. coli that were 9.88 ×1021 and 9.118 ×1014 were selected as  




Fig. 5 — MBC analysis of verapamil hydrochloride. a and b 
represent E. faecalis and E. coli, respectively, also the number of 
1, 2, 3, 4 and 5 represent 25, 18, 9, 1.5 and 0.75 mM of verapamil 
hydrochloride, respectively 




the inexpensive, rapid, and valuable method is the 
incubation of a supercoiled plasmid DNA with the 
selected chemical followed by agarose gel 
electrophoresis
21
. DNA breakage can be analyzed by 
study conversion of supercoiled pUC19 plasmid DNA 
into relaxed circular and linear forms of DNA. The 
intact pUC19 plasmid DNA is found in supercoiled 
form while pUC19 plasmid DNA with a single strand 
break is in relaxed circular form and finally, plasmid 
DNA with breaks in both strands is found in linear 
form. Using this information, the breaking potential of 
verapamil hydrochloride on DNA was determined by 
gel electrophoresis analysis of pUC19 after treatment 
with different concentrations of verapamil hydro-
chloride. Human physiological plasma iron and 
copper total concentrations (free and bound) range 
between (11-31 µM) and (14-19 µM), respectively
22
. 
Copper is one of the most redox-active metal ions 
found in cells and is closely associated with 
chromatin 
23
. The concentration of verapamil in 
human plasma had been reported to be as almost 
0.055-0.355 mg/mL
24
 and 10-500 ng/mL
25
. Blood 
level data are important to study the toxic effect of 
drugs and chemicals
24
. Therefore, iron, copper and 
verapamil hydrochloride concentrations have been 
selected considering their concentrations in human 
plasma. In this study, the supercoiled pUC19 plasmid 
DNA was not broken by verapamil hydrochloride 






reported to beak DNA. In addition, verapamil 
hydrochloride could not protect the DNA against 
damaging hydroxyl radicals generated by Fenton 
reactions. UV-visible spectroscopy is the most 
common method to study drug-DNA interaction. 
After binding of a drug to DNA, in the spectrum of 
DNA hypochromic effects occurred due to changes in 
the conformation and structure of DNA
20
. A 
hyperchromic effect is due to the binding of 
chemicals to DNA which might result in the 
unwinding of DNA helix
28
. In UV-Vis 
spectrophotometry analysis, the absorbance of ctDNA 
did not show any changes by the addition of 
verapamil hydrochloride, in other words, verapamil 
hydrochloride did not interact with ctDNA. On the 
other hand in docking study, verapamil hydrochloride 
showed to make one hydrogen bond (DG4: O3 - Vera: 
O1) and some hydrophobic bonds with DNA. In this 
study, PBS was used as a solvent buffer, therefore we 
think that the result of UV-Vis spectrophotometry 
analysis was because of the NaCl present in PBS 
buffer that decreased hydrophobicity of the drug. 
Grujicic et al. 
29
 showed that the rate of micronucleus 
in peripheral blood lymphocytes of pregnant women 
treated with verapamil hydrochloride was increased. 
In this study, the three high concentrations of 
verapamil hydrochloride showed a significant 
cytotoxic effect on E. faecalis and E. coli. 
Considering the mean fluid volume in the small 
intestine (105±72 mL and 54±41 mL, P <0.01)
30
, the 
oral doses of verapamil hydrochloride (40-400 mg) 
make the concentration of 0.75, 1.5, 9, 18 and 25 mM 
that were used in this research to study the drug 
antibacterial effects. The clinical manifestations of 
arthritis were appeared by the expression of beta-
galactosidase by E. coli. In addition decrease of E. 
coli strain in the intestinal of the patients with 
ulcerative colitis cause to increase in the amount of 
non-normal flora bacteria even pathogenic strains in 
the intestinal tract
31
. Because colicin proteins 
expressed by E. coli inhibit bacterial growth of other 
species
32
. The growth of E. faecalis, Gram positive 
strain, was affected by all of the concentrations of 
verapamil hydrochloride. The drug affected the 
growth processes of these two bacterial strains, 
leading to disruption of intestinal homeostasis. This 
can lead to disbalance in the gastrointestinal tract, 
causing dysbiosis, change or deterioration in the 
structure of the microbiota, resulting in serious 





Verapamil hydrochloride showed a significantly 
high antibacterial effect on the bacterial strains 
Enterococcus faecalis and Escherichia coli from 
human intestinal flora. The results of this study have 
shown that the drug did not break double helix DNA 
even in the presence of H2O2 and ascorbic acid. 
Further, the drug did not show any protective effect 
on the supercoiled plasmid DNA against damaging 
hydroxyl radicals. In addition, the drug made 
remarkable hydrophobic bonds with double strand 
DNA. Therefore, the cytotoxic and genotoxic effects 
of the drug can be attributed not to its direct effect on 
DNA, but to the metabolite of the drug. 
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